EQ Chart
- 52-Week Range: $2.18 - $7.64
- Market Capitalization: $85.69M
- Short Percentage: 0%
- Target Price: $13.17
- Shares Outstanding: 34.28M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
EQ released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Equillium Acquires Bioniz Therapeutics Significantly Expanding Pipeline of Novel Immunomodulatory Drug CandidatesBusiness Wire | February 16th
- Equillium to Present at the SVB Leerink Virtual Global Healthcare ConferenceBusiness Wire | February 9th
- Equillium Announces Data from Phase 1b EQUIP Study in Patients with Uncontrolled AsthmaBusiness Wire | January 4th
- Equillium Announces Two Abstracts Accepted for Presentation at the 63rd ASH Annual Meeting and ExpositionBusiness Wire | November 4th
- Equillium Announces Multiple Abstracts Accepted for Presentation at ACR Convergence 2021Business Wire | September 30th
- Equillium to Present at the Cantor Fitzgerald Virtual Global Healthcare ConferenceBusiness Wire | September 22nd
- Equillium to Present at the H.C. Wainwright 23rd Annual Global Investment ConferenceBusiness Wire | September 8th
Company Info
Website: https://equilliumbio.com
Address: 2223 Avenida De La Playa, La Jolla, CA, United States, 92037
Sector: Healthcare
Industry: Biotechnology
Full time employees: 45
Address: 2223 Avenida De La Playa, La Jolla, CA, United States, 92037
Sector: Healthcare
Industry: Biotechnology
Full time employees: 45
$EQ is going to have a run next month
$EQ I hate this company.
$EQ has just been halted from trading due to volatility.
$EQ TRUST THE PROCESS! BUY AND HOLD! OUR TIME IS COMING$$$
$EQ Free money indeed??
$EQ Very bullish action
$EQ Markets about as efficient as a retirement home
$EQ lets go!!